WallStSmart

Creative Realities Inc (CREX)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Zepp Health Corp generates 352% more annual revenue ($258.90M vs $57.23M). CREX leads profitability with a -14.5% profit margin vs -15.5%. CREX earns a higher WallStSmart Score of 50/100 (D+).

CREX

Hold

50

out of 100

Grade: D+

Growth: 6.0Profit: 3.0Value: 8.3Quality: 5.0

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CREXUndervalued (+52.5%)

Margin of Safety

+52.5%

Fair Value

$6.66

Current Price

$3.65

$3.01 discount

UndervaluedFair: $6.66Overvalued
ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CREX3 strengths · Avg: 9.3/10
PEG RatioValuation
0.4810/10

Growing faster than its price suggests

Revenue GrowthGrowth
117.2%10/10

Revenue surging 117.2% year-over-year

Price/BookValuation
1.8x8/10

Reasonable price relative to book value

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

CREX4 concerns · Avg: 2.3/10
Market CapQuality
$40.47M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-22.2%2/10

ROE of -22.2% — below average capital efficiency

EPS GrowthGrowth
-32.7%2/10

Earnings declined 32.7%

Free Cash FlowQuality
$-7.01M2/10

Negative free cash flow — burning cash

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : CREX

The strongest argument for CREX centers on PEG Ratio, Revenue Growth, Price/Book. Revenue growth of 117.2% demonstrates continued momentum. PEG of 0.48 suggests the stock is reasonably priced for its growth.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : CREX

The primary concerns for CREX are Market Cap, Return on Equity, EPS Growth.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.

CREX is growing revenue faster at 117.2% — sustainability is the question.

Monitor SOFTWARE - APPLICATION industry trends, competitive dynamics, and regulatory changes.

Bottom Line

CREX scores higher overall (50/100 vs 41/100) and 117.2% revenue growth. ZEPP offers better value entry with a 48.6% margin of safety. Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Creative Realities Inc

TECHNOLOGY · SOFTWARE - APPLICATION · USA

Creative Realities, Inc. provides digital marketing technology solutions to retail companies, individual retail brands, businesses, and other organizations in the United States and Canada.

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?